Skip to content
Open access

Mitochondrial and protein homeostasis pathways are transcriptionally impaired in islets during type 1 diabetes pathogenesis

Aug 2026 · bioRxiv · 0 citations
Biology

TL;DR

These studies identified novel mechanisms of β-cell dysregulation before symptomatic onset and independent of T-cell infiltration in T1D pathogenesis.

Abstract

The decline in first-phase insulin response (FPIR) during the presymptomatic period of type 1 diabetes (T1D) is well established. In-situ functional studies with pancreas tissue slices showed that β-cell loss of glucose-responsiveness was independent of T-cell infiltration into islets in recent-onset T1D cases. However, the mechanisms driving β-cell dysfunction before the onset of T1D remain unclear. In pancreas tissue from donors across the natural history of T1D, we utilized an in-situ, whole-islet phenotypical and transcriptomic approach to unravel novel targets in the glucose-stimulus coupled secretion pathway that are similarly impaired in T-cell infiltrated and non-infiltrated islets. Specifically, we observed that islets from autoantibody positive (single(s) or multiple(m) AAb+) donors exhibited activation of post-transcriptional gene regulation along with reduced protein translation, processing in the endoplasmic reticulum (ER), and ER stress. Disrupted mitochondrial metabolism and bioenergetics were prominent in islets from multiple AAb+ and T1D donors with disease durations ≤7 years. In addition, T1D islets presented reduced mitochondrial protein import, quality control, and dynamics, together with downregulated genes in insulin secretory pathways. During infiltration, these pathways remain dysregulated while immune/inflammatory transcripts were increased. These studies identified novel mechanisms of β-cell dysregulation before symptomatic onset and independent of T-cell infiltration in T1D pathogenesis.

Read PDF

Similar papers

Review Open access Aug 2026

The integrated stress response in pancreatic β-cell failure in diabetes: from molecular mechanisms to precision therapeutics

Diabetes mellitus is a global metabolic disorder characterized by progressive pancreatic β-cell failure, which leads to inadequate insulin secretion, often in combination with insulin resistance, and ultimately disrupts glucose homeostasis. The Integrated Stress Response (ISR), a crucial signaling network that enables...

Yi-Jun Huang, Yu Zeng, Xinying Zhong et al. · 0 citations
Review Open access Sep 2026

Mitochondria–Endoplasmic Reticulum Crosstalk in Pancreatic β-Cell Stress: A Driver of Diabetes

Pancreatic β-cell failure is central to the pathogenesis of type 2 diabetes (T2D), developing when chronic metabolic stress overwhelms the adaptive capacity of these cells. Because insulin biosynthesis and glucose-stimulated secretion depend on tightly coordinated organelle function, crosstalk between the endoplasmic r...

S. Niinuma, A. S. Takemoto, William Junior Khalil et al. · 0 citations
Review Open access 2021

Insulin physiology and metabolic control: current concepts and perspectives

Type 2 diabetes (T2D) results from progressive failure of multiple interconnected metabolic nodes. This review synthesizes evidence that β-cell dedifferentiation, mediated by loss of PDX-1, MAFA, and NKX6.1 and by epigenetic silencing of their promoters, may represent a leading mechanism of β-cell dysfunction, potentia...

Cozar-Castellano Irene, L. Astrid, Perdomo German et al. · 0 citations
Review Open access Aug 2026

Organelle-specific crosstalk between calcium and redox signaling in pancreatic β-cells in physiology and type 2 diabetes

Two of the main intracellular signaling molecules in pancreatic β-cells are calcium (Ca2+) and reactive oxygen species (ROS). Ca2+ signaling is essential for regulating energy metabolism, insulin secretion, and the modulation of key factors involved in β-cell survival and function. In parallel, redox signaling also aff...

Lucas Rafael Pereira Camara, E. Vilas-Boas · 0 citations
Open access Sep 2026

miRNAs as cell-intrinsic epigenetic regulators in muscle in type 2 diabetes

miRNAs are important metabolic regulators and are altered at both the cellular and secreted levels in diseases, including type 2 diabetes (T2D). However, to what extent these alterations are in response to factors in the in vivo milieu or are cell-intrinsic remains unclear. Here we used a disease-in-a-dish model in whi...

Allah Nawaz, Marsel Lino, N. Haider et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.